Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Today's Latest Price: $1.20 USD

0.02 (-1.64%)

Updated Nov 25 4:00pm

Add CRBP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

CRBP Stock Summary

  • As for revenue growth, note that CRBP's revenue has grown -83.81% over the past 12 months; that beats the revenue growth of just 1.7% of US companies in our set.
  • In terms of volatility of its share price, CRBP is more volatile than 94.78% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CRBP comes in at -135.83% -- higher than that of merely 2.71% of stocks in our set.
  • Stocks that are quantitatively similar to CRBP, based on their financial statements, market capitalization, and price volatility, are MTEM, NXTC, NTLA, KALV, and FIXX.
  • Visit CRBP's SEC page to see the company's official filings. To visit the company's web site, go to

CRBP Stock Price Chart Interactive Chart >

Price chart for CRBP

CRBP Price/Volume Stats

Current price $1.20 52-week high $9.78
Prev. close $1.22 52-week low $0.91
Day low $1.19 Volume 2,381,100
Day high $1.23 Avg. volume 2,500,956
50-day MA $1.29 Dividend yield N/A
200-day MA $5.09 Market Cap 100.84M

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.

CRBP Latest News Stream

Event/Time News Detail
Loading, please wait...

CRBP Latest Social Stream

Loading social stream, please wait...

View Full CRBP Social Stream

Latest CRBP News From Around the Web

Below are the latest news stories about Corbus Pharmaceuticals Holdings Inc that investors may wish to consider to help them evaluate CRBP as an investment opportunity.

Cannabis Stock Gainers And Losers From September 29, 2020

GAINERS: 48North Cannabis (PINK: NCNNF ) shares closed up 27.27% at $0.14 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 20.12% at $1.97 GrowGeneration (NASDAQ: GRWG ) shares closed up 9.13% at $16.02 Aleafia Health (OTCQX: ALEAF ) shares closed up 7.71% at $0.37 CV Sciences (OTCQB: CVSI ) shares closed up 7.57% at $0.54 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 6.78% at $1.26 Item 9 Labs (OTCQX: INLB ) shares closed up 1.33% at $6.4 BioHarvest Sciences (OTC: CNVCF) shares closed up … Full story available on

Benzinga | September 29, 2020

Cannabis Stock Gainers And Losers From September 9, 2020

Gainers: AusCann Group Holdings (OTC: ACNNF ) shares closed up 24.11% at $0.12 Heritage Cannabis Holding (OTC: HERTF ) shares closed up 18.04% at $0.08 NexTech AR Solns (OTC: NEXCF ) shares closed up 13.42% at $4.09 Cann Gr (OTC: CNGGF ) shares closed up 10.34% at $0.32 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 9.42% at $2.44 Emerald Health (OTC: EMHTF ) shares closed up 8.74% at $0.17 Bloom Energy (NYSE: BE ) … Full story available on

Benzinga | September 9, 2020

The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-o...

Benzinga | September 9, 2020

Why Corbus Pharma Shares Are Sinking

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares were plummeting hard Tuesday following an adverse clinical data readout. What Happened: Top-line …

Benzinga | September 8, 2020

The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Fluidigm Corporation (NASDAQ: FLDM ) ( announced emergency use authorization for its saliva-based COVID-19 test) Generation Bio Co (NASDAQ: GBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc. (NASDAQ: LTRN ) Ocular Therapeutix Inc (NASDAQ: OCUL ) PPD Inc (NASDAQ: PPD ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Revance Therapeutics Inc (NASDAQ: RVNC ) Silk Road Medical Inc (NASDAQ: SILK ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 26) Odonate Therapeutics Inc (NASDAQ: ODT ) Polypid Ltd (NASDAQ: PYPD ) Stocks In Focus FDA Approves Companion Diagnos...

Benzinga | August 27, 2020

Read More 'CRBP' Stories Here

CRBP Price Returns

1-mo 24.52%
3-mo -85.98%
6-mo -83.91%
1-year -73.74%
3-year -82.86%
5-year -33.33%
YTD -78.02%
2019 -6.51%
2018 -17.75%
2017 -15.98%
2016 412.12%
2015 -44.82%

Continue Researching CRBP

Here are a few links from around the web to help you further your research on Corbus Pharmaceuticals Holdings Inc's stock as an investment opportunity:

Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price | Nasdaq
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Quote, History and News - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8735 seconds.